Nanotechnology Characterization Laboratory
|
Research Initiative
|
FDA
|
NCI, NIEHS
|
2004
|
|
National Action Alliance for Suicide Prevention (NAASP)
|
Committee, Advisory Group, or Work Group
|
ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA
|
NIAAA, NIDA, NIMH, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2010
|
|
NATIONAL ACTION PLAN FOR COMBATING ANTIBIOTIC-RESISTANT BACTERIA (CARB) 2020-2025
|
Committee, Advisory Group, or Work Group
|
AHRQ, BARDA, CDC, CMS, FDA, HRSA, OS
|
NIAID
|
2019
|
|
National Action Plan for the Elimination of MDR TB
|
Other
|
CDC
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NICHD, NIDA
|
2015
|
|
National Advisory Board for Medical Rehabilitation Research
|
Committee, Advisory Group, or Work Group
|
ACL, CDC
|
NHLBI, NIA, NIAMS, NICHD, NIDCD, NINDS, OD/ DPCPSI
|
1991
|
|
National Amyotrophic Lateral Sclerosis (ALS) Registry
|
Resource Development
|
ATSDR, CDC
|
NINDS
|
2011
|
|
National Cancer Control Strategy
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI
|
2017
|
|
National Center for Advancing Translational Sciences (NCATS) Patient-focused Therapeutics Development Toolkit
|
Resource Development
|
FDA
|
NCATS
|
2017
|
|
National Clinical Care Commission
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, FDA, HRSA, IHS
|
NIDDK
|
2018
|
|
National Clinical Trials Network (NCTN) Scientific Steering Committees (SSCs)
|
Committee, Advisory Group, or Work Group
|
FDA
|
NCI
|
2008
|
|
National Coalition for Oversite of Assisted Reproductive Technologies (NCOART)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
1997
|
|
National Collaborative on Childhood Obesity Research (NCCOR)
|
Research Initiative
|
CDC
|
NCI, NHLBI, NICHD, NIDDK, OD/ DPCPSI/ OBSSR, OD/ DPCPSI/ ODP
|
2009
|
|
National Database for Antibiotic Resistant Organisms (NDARO)
|
Resource Development
|
CDC, FDA
|
CC, FIC, NCATS, NCI, NHLBI, NIA, NIAAA, NIAID, NIDA
|
2016
|
|
National Death Index Linkage Collaboration
|
Resource Development
|
CDC
|
OD/ DPCPSI/ OBSSR, OD/ IMOD
|
2019
|
|
National Death Index Working Group
|
Committee, Advisory Group, or Work Group
|
CDC
|
NIA, NICHD, OD/ DPCPSI/ OBSSR
|
2018
|
|
National Diabetes Education Program (NDEP)
|
Public Education Campaign
|
AHRQ, CDC, HRSA, IHS
|
NEI, NHLBI, NIA, NIDDK
|
1997
|
|
National Emerging Technologies Committee
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NICHD
|
2005
|
|
National Family Health History Group
|
Public Education Campaign
|
CDC
|
CC, NHGRI, OD/ OSP
|
2005
|
|
National Health Interview Survey (NHIS) Cancer Control Supplement
|
Health Survey
|
CDC
|
NCI
|
1992
|
|
National Healthcare Quality and Disparities (NHQDR) Inter-Agency Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, CMS, HRSA
|
NCI, NIAID, NIEHS, NIMHD
|
2004
|
|
National Hispanic Science Network (NHSN)
|
Meeting/ Workshop
|
AHRQ, CDC, SAMHSA
|
NIAAA, NIDA, NIMH
|
2001
|
|
National Institute on Deafness and Other Communication Disorders (NIDCD) Directory of Organizations
|
Resource Development
|
AHRQ, CDC, CMS
|
NIDCD
|
1995
|
|
National Institutes of Health (NIH) Flow Cytometry Interest Group
|
Committee, Advisory Group, or Work Group
|
FDA
|
CC, NCI, NEI, NHLBI, NIAID, NIAMS, NIDCR
|
2005
|
|
National Institutes of Health (NIH) Metabolomics Scientific Interest Group
|
Other
|
FDA
|
NCI, NHLBI, NIA, NIAAA, NIAID, NIDCR, NIDDK, NIEHS, NIMH, NLM, OD/ DPCPSI/ ODS
|
2007
|
|
National Interagency Confederation for Biological Research
|
Committee, Advisory Group, or Work Group
|
CDC, FDA
|
NCI, NIAID
|
2002
|
|
|